Skip to main content

Closed

GALT: Galectin Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-192.3%

Financially safe

Stretched

Debt / equity-1.04×

Interest coverage-2.1×

Current ratio2.15×

Galectin Therapeutics Inc.

GALTNASDAQ Capital Market·USD·Closed

Galectin Therapeutics Inc.

GALTNASDAQ·USD·Closed

$2.97

−8.05%

$2.97

−$0.26 (8.05%)

52W Range

18thpctl

Volume

0.58×avg

Mkt Cap

195.59MUSD

P/E

-7.3TTM

Div Yield

–ann

52W Range

18thpctl

Volume

0.58×avg

Market Cap

195.59MUSD

P/E Ratio

-7.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings